Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #4441 on Skye Bioscience Inc (SKYE)
Quintessence
02/15/18 11:23 AM
#4442 RE: MADDSTACKER #4441
MERCURIAL
02/15/18 11:53 AM
#4444 RE: MADDSTACKER #4441
The company is advancing preclinical development with the intent to launch a Phase 1 clinical study in 2018.
TheMonolith
02/15/18 12:03 PM
#4446 RE: MADDSTACKER #4441